BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 27222797)

  • 1. The volumetric and shape changes of the putamen and thalamus in first episode, untreated major depressive disorder.
    Lu Y; Liang H; Han D; Mo Y; Li Z; Cheng Y; Xu X; Shen Z; Tan C; Zhao W; Zhu Y; Sun X
    Neuroimage Clin; 2016; 11():658-666. PubMed ID: 27222797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
    Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
    EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal brain volume changes in major depressive disorder.
    Yüksel D; Engelen J; Schuster V; Dietsche B; Konrad C; Jansen A; Dannlowski U; Kircher T; Krug A
    J Neural Transm (Vienna); 2018 Oct; 125(10):1433-1447. PubMed ID: 30167933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical grey matter changes in untreated, early stage Parkinson's disease without dementia.
    Lee HM; Kwon KY; Kim MJ; Jang JW; Suh SI; Koh SB; Kim JH
    Parkinsonism Relat Disord; 2014 Jun; 20(6):622-6. PubMed ID: 24703894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced thalamic volumes in major depressive disorder.
    Nugent AC; Davis RM; Zarate CA; Drevets WC
    Psychiatry Res; 2013 Sep; 213(3):179-85. PubMed ID: 23850106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal and subcortical alterations of first-episode, medication-naïve major depressive disorder with panic disorder patients.
    Lai CH
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):142-9. PubMed ID: 24509652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grey matter volume abnormalities in the first depressive episode of medication-naïve adult individuals: a systematic review of voxel based morphometric studies.
    Amidfar M; Quevedo J; Z Réus G; Kim YK
    Int J Psychiatry Clin Pract; 2021 Nov; 25(4):407-420. PubMed ID: 33351672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential brain structural alterations in major depressive disorder: A voxel-wise meta-analysis on first episode, medication-naive patients.
    Peng W; Chen Z; Yin L; Jia Z; Gong Q
    J Affect Disord; 2016 Jul; 199():114-23. PubMed ID: 27100056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain grey matter abnormalities in medication-free patients with major depressive disorder: a meta-analysis.
    Zhao YJ; Du MY; Huang XQ; Lui S; Chen ZQ; Liu J; Luo Y; Wang XL; Kemp GJ; Gong QY
    Psychol Med; 2014 Oct; 44(14):2927-37. PubMed ID: 25065859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain structural alterations in MDD patients with gastrointestinal symptoms: Evidence from the REST-meta-MDD project.
    Liu PH; Li Y; Zhang AX; Sun N; Li GZ; Chen X; Bai TJ; Bo QJ; Chen GM; Chen NX; Chen TL; Chen W; Cheng C; Cheng YQ; Cui XL; Duan J; Fang YR; Gong QY; Guo WB; Hou ZH; Hu L; Kuang L; Li F; Li KM; Li T; Liu YS; Liu ZN; Long YC; Luo QH; Meng HQ; Peng DH; Qiu HT; Qiu J; Shen YD; Shi YS; Wang F; Wang K; Wang L; Wang X; Wang Y; Wu XP; Wu XR; Xie CM; Xie GR; Xie HY; Xie P; Xu XF; Yang H; Yang J; Yao JS; Yao SQ; Yin YY; Yuan YG; Zhang H; Zhang L; Zhang ZJ; Zhou RB; Zhou YT; Zhu JJ; Zou CJ; Si TM; Zuo XN; Yan CG; Zhang KR
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110386. PubMed ID: 34119573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disorder-specific volumetric brain difference in adolescent major depressive disorder and bipolar depression.
    MacMaster FP; Carrey N; Langevin LM; Jaworska N; Crawford S
    Brain Imaging Behav; 2014 Mar; 8(1):119-27. PubMed ID: 24158718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amygdala Atrophy and Its Functional Disconnection with the Cortico-Striatal-Pallidal-Thalamic Circuit in Major Depressive Disorder in Females.
    Yang J; Yin Y; Svob C; Long J; He X; Zhang Y; Xu Z; Li L; Liu J; Dong J; Zhang Z; Wang Z; Yuan Y
    PLoS One; 2017; 12(1):e0168239. PubMed ID: 28107446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of subcortical grey matter abnormalities in patients with MRI-negative cortical epilepsy determined through structural and tensor magnetic resonance imaging.
    Peng SJ; Harnod T; Tsai JZ; Ker MD; Chiou JC; Chiueh H; Wu CY; Hsin YL
    BMC Neurol; 2014 May; 14():104. PubMed ID: 24885823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjoint and dissociated structural and functional abnormalities in first-episode drug-naive patients with major depressive disorder: a multimodal meta-analysis.
    Wang W; Zhao Y; Hu X; Huang X; Kuang W; Lui S; Kemp GJ; Gong Q
    Sci Rep; 2017 Sep; 7(1):10401. PubMed ID: 28871117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local shape volume alterations in subcortical structures of suicide attempters with major depressive disorder.
    Kang W; Shin JH; Han KM; Kim A; Kang Y; Kang J; Tae WS; Paik JW; Lee HW; Seong JK; Ham BJ
    Hum Brain Mapp; 2020 Dec; 41(17):4925-4934. PubMed ID: 32804434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcortical Volume Loss in the Thalamus, Putamen, and Pallidum, Induced by Traumatic Brain Injury, Is Associated With Motor Performance Deficits.
    Gooijers J; Chalavi S; Beeckmans K; Michiels K; Lafosse C; Sunaert S; Swinnen SP
    Neurorehabil Neural Repair; 2016 Aug; 30(7):603-14. PubMed ID: 26498433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcortical shape alterations in major depressive disorder: Findings from the ENIGMA major depressive disorder working group.
    Ho TC; Gutman B; Pozzi E; Grabe HJ; Hosten N; Wittfeld K; Völzke H; Baune B; Dannlowski U; Förster K; Grotegerd D; Redlich R; Jansen A; Kircher T; Krug A; Meinert S; Nenadic I; Opel N; Dinga R; Veltman DJ; Schnell K; Veer I; Walter H; Gotlib IH; Sacchet MD; Aleman A; Groenewold NA; Stein DJ; Li M; Walter M; Ching CRK; Jahanshad N; Ragothaman A; Isaev D; Zavaliangos-Petropulu A; Thompson PM; Sämann PG; Schmaal L
    Hum Brain Mapp; 2022 Jan; 43(1):341-351. PubMed ID: 32198905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampus-driving progressive structural alterations in medication-naïve major depressive disorder.
    Li Y; Wang C; Teng C; Jiao K; Song X; Tan Y; Xiao C; Zhang N; Zhong Y
    J Affect Disord; 2019 Sep; 256():148-155. PubMed ID: 31176187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of decreased gray matter concentration in the midbrain encompassing the dorsal raphe nucleus and the limbic subcortical regions in major depressive disorder: an optimized voxel-based morphometry study.
    Lee HY; Tae WS; Yoon HK; Lee BT; Paik JW; Son KR; Oh YW; Lee MS; Ham BJ
    J Affect Disord; 2011 Sep; 133(1-2):128-36. PubMed ID: 21546094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural equation modeling and principal component analysis of gray matter volumes in major depressive and bipolar disorders: differences in latent volumetric structure.
    Yeh PH; Zhu H; Nicoletti MA; Hatch JP; Brambilla P; Soares JC
    Psychiatry Res; 2010 Dec; 184(3):177-85. PubMed ID: 21051206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.